Funded Tech Companies
Alentis Therapeutics
Alentis Therapeutics, operating out of Allschwil, received equity investments from OrbiMed, Catalio Capital Management and Jeito Capital.
Company Overview
Company Name
Alentis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Hegenheimermattweg 167A
Allschwil, 4123
CH
Allschwil, 4123
CH
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Alentis Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough treatments for cancer and fibrotic diseases. Claudin-1 (CLDN1) is a member of the tight junction proteins family. During disease pathogenesis, CLDN1 expression is up-regulated and exposed outside of the tight junction. Exposed, non--tight junctional, CLDN1 drives carcinogenic and fibrogenic signaling in different organs.
Last Transaction
11/12/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- OrbiMed
- Catalio Capital Management
- Jeito Capital
- RA Capital Management
- Longitude Capital Management
- Frazier Life Sciences
- Morningside Ventures
- Novo Holdings
- InnoBio Fund
- BB Pureos Bioventures
- Bpifrance
- Schroders Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs